DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06108 ** SEE <2908.HK>

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Eagle Amber Holdings Limited (25.52%)
Zhou Ling (9.65%)
Qian Shenglei (7.16%)
Sector Health Care & Biotechnology
Web Site http://www.newraymedicine.com Tel (852) 2152-2030
Email info@newraymedicine.com Fax N/A
Related Equities N/A
Principal Activities The Group is an established pharmaceutical distributor principally engaged in the distribution and trading of pharmaceutical products and the provision of marketing and promotion services in the PRC.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
于文勇 268,696,000(L)  16.07(L)  10/04/2018
钱晟磊 193,704,000(L)  11.59(L)  14/02/2018
China Wah Yan Healthcare Limited 137,427,840(L)  8.22(L)  17/04/2018
周凌 112,728,000(L)  6.74(L)  27/06/2018
楊芳 112,728,000(L)  6.74(L)  27/06/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top